SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001144204-17-065936
Filing Date
2017-12-29
Accepted
2017-12-29 17:25:14
Documents
6
Group Members
CATALYST CEL FUND L.P.CEL CATALYST CHINA ISRAEL FUND L.P.CEL CATALYST CHINA ISRAEL GENERAL PARTNER LTD

Document Format Files

Seq Description Document Type Size
1 SC 13G tv482324_sc13g.htm SC 13G 99491
2 EXHIBIT 1 tv482324_ex1.htm EX-1 7744
3 EXHIBIT 2 tv482324_ex2.htm EX-2 9480
4 EXHIBIT 3 tv482324_ex3.htm EX-3 9646
5 EXHIBIT 4 tv482324_ex4.htm EX-4 9342
6 EXHIBIT 5 tv482324_ex5.htm EX-5 9377
  Complete submission text file 0001144204-17-065936.txt   146951
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Subject) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-56243 | Film No.: 171282732
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 28 HAARBAA ST. TEL AVIV L3 6473925
Business Address 28 HAARBAA ST. TEL AVIV L3 6473925 972-3-6950666
Catalyst CEL Management Ltd. (Filed by) CIK: 0001726536 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: SC 13G